Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats

Acta Pharmacologica Sinica

Volumn 32, Issue 7, 2011, Pages 956-966

  Zhang, Lu Lu ^a   Lu, Liang ^a   Jin, Shi ^a   Jing, Xin Yue ^a   Yao, Dan ^a   Hu, Nan ^a   Liu, Li ^a   Duan, Ru ^a   Liu, Xiao Dong ^a   Wang, Guang Ji ^a   Xie, Lin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

ABC superfamily transporter; Abcb1 P GP gene; diabetes mellitus; insulin; P glycoprotein; rhodamine 123

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA; PROTEIN; RHODAMINE 123; STREPTOZOCIN;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY FLUID; BRAIN CORTEX; DIABETES MELLITUS; INTESTINE MUCOSA; KIDNEY PARENCHYMA; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; WESTERN BLOTTING;

ANIMALS; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; HIPPOCAMPUS; INTESTINAL MUCOSA; KIDNEY; LIVER; MALE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 79960043080     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.33     Document Type: Article

References (57)

1. Bae SK, Yang SH, Lee SJ, Kwon JW, Kim WB, Lee DC, et al. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin. Eur J Pharm Sci 2005; 25: 337-45. (Pubitemid 40725065)
2. Kim YC, Oh EY, Kim SH, Lee MG. Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin. Biopharm Drug Dispos 2005; 26: 371-8. (Pubitemid 41684542)
3. Kim YC, Oh EY, Kim SH, Lee MG. Pharmacokintics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin. Biopharm Drug Dispos 2006; 27: 85-92.
4. Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, Klaassen CD. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos 2002; 30: 838-44. (Pubitemid 34671097)
5. Marchetti S, Mazzanti R, Beijnen JH, Schellens JH. Concise review: clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 2007; 12: 927-41. (Pubitemid 47359135)
6. Dey S, Patel J, Anand BS, Jain-Vakkalagadda B, Kaliki P, Pal D, et al. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest Ophthalmol Vis Sci 2003; 44: 2909-18. (Pubitemid 36759752)
7. Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004; 25: 423-9. (Pubitemid 38981558)
8. Nishio N, Katsura T, Ashida K, Okuda M, Inui K. Modulation of P-glycoprotein expression in hyperthyroid rat tissues. Drug Metab Dispos 2005; 33: 1584-7. (Pubitemid 41539952)
9. Yu DK. The contribution of P-glycoprotein to pharmacokinetic drugdrug interactions. J Clin Pharmacol 1999; 39: 1203-11. (Pubitemid 30644000)
10. Liu XD, Pan GY, Xie L, Hou YY, Lan W, Su Q, et al. Cyclosporine A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats. Acta Pharmacol Sin 2002; 23: 225-9. (Pubitemid 34194388)
11. Lickteig AJ, Fisher CD, Augustine LM, Aleksunes LM, Besselsen DG, Slitt AL, et al. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metab Dispos 2007; 35: 1970-8. (Pubitemid 47481594)
12. Naud J, Michaud J, Boisvert C, Desbiens K, Leblond FA, Mitchell A, et al. Down-regulation of intestinal drug transporters in chronic renal failure in rats. J Pharmacol Exp Ther 2007; 320: 978-85. (Pubitemid 46294060)
13. Tada Y, Wada M, Kuroiwa K, Kinugawa N, Harada T, Nagayama J, et al. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Clin Cancer Res 2000; 6: 4618-27. (Pubitemid 32110396)
14. Yu S, Yu Y, Liu L, Wang X, Lu S, Liang Y, et al. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved? Planta Med 2010; 76: 876-81.
15. Liu H, Zhang D, Xu X, Liu X, Wang G, Xie L, et al. Attenuated function and expression of P-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice. Eur J Pharmacol 2007; 561: 226-32. (Pubitemid 46435862)
16. Liu H, Xu X, Yang Z, Deng Y, Liu X, Xie L. Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin- induced diabetic rats. Brain Res 2006; 1123: 245-52.
17. Nawa A, Fujita Hamabe W, Tokuyama S. Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions. Life Sci 2010; 86: 402-9.
18. Tramonti G, Xie P, Wallner EI, Danesh FR, Kanwar YS. Expression and functional characteristic of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes. Am J Physiol Renal Physiol 2006; 291: 972-80.
19. van Waarde WM, Verkade HJ, Wolters H, Havinga R, Baller J, Bloks V, et al. Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. Gastroenterology 2002; 122: 1842-52. (Pubitemid 34651429)
20. Kamei J, Hirano S, Miyata S, Saitoh A, Onodera K. Effects of firstand second-generation histamine-H1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocininduced diabetic mice. J Pharmacol Sci 2005; 97: 266-72. (Pubitemid 40410267)
21. Ke LD, Chen Z, Yung WK. A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards. Mol Cell Probes 2000; 14: 127-35. (Pubitemid 30330661)
22. Liu W, Saint DA. Validation of a quantitative method for real time PCR kinetics. Biochem Biophys Res Commun 2002; 294: 347-53. (Pubitemid 34694101)
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδct method. Methods 2001; 25: 402-8. (Pubitemid 34164012)
24. Applied-Biosystems. Relative quantitation of gene expression. User Bulletin #2. ABI PRISM 7700 Sequence Detection System. 1997.
25. Jing X, Liu X, Wen T, Xie S, Yao D, Liu X, et al. Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats. Br J Pharmacol 2010; 159: 1511-22.
26. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491-502. (Pubitemid 24153990)
27. Bond TD, Valverde MA, Higgins CF. Protein kinase C phosphorylation disengages human and mouse-1a P-glycoproteins from influencing the rate of activation of swelling-activated chloride currents. J Physiol 1998; 508: 333-40. (Pubitemid 28203950)
28. Lecureur V, Thottassery JV, Sun D, Schuetz EG, Lahti J, Zambetti GP, et al. Mdr1b facilitates p53-mediated cell death and p53 is required for Mdr1b upregulation in vivo. Oncogene 2001; 20: 303-13. (Pubitemid 32142319)
29. Zhou G, Kuo MT. Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin. J Biol Chem 1998; 273: 15387-94. (Pubitemid 28298143)
30. Ziemann C, Bürkle A, Kahl GF, Hirsch-Ernst KI. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Carcinogenesis 1999; 20: 407-14. (Pubitemid 29112627)
31. Liu H, Liu X, Jia L, Liu Y, Yang H, Wang G, et al. Insulin therapy restores impaired function and expression of P-glycoprotein in bloodbrain barrier of experimental diabetes. Biochem Pharmacol 2008; 75: 1649-58.
32. Liu H, Yang H, Wang D, Liu Y, Liu X, Li Y, et al. Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-?B pathway but not a PI3K/Akt pathway. Eur J Pharmacol 2009; 602: 277-82.
33. Kameyama N, Arisawa S, Ueyama J, Kagota S, Shinozuka K, Hattori A, et al. Increase in P-glycoprotein accompanied by activation of protein kinase C alpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. Biochim Biophys Acta 2008; 1782: 355-60.
34. Barta CA, Sachs-Barrable K, Feng F, Wasan KM. Effects of monoglycerides on P-glycoprotein: modulation of the activity and expression in Caco-2 cell monolayers. Mol Pharm 2008; 5: 863-75.
35. Nishimura A, Honda N, Sugioka N, Takada K, Shibata N. Evaluation of carbamazepine pharmacokinetic profiles in mice with kainic acidinduced acute seizures. Biol Pharm Bull 2008; 31: 2302-8.
36. Pires MM, Emmert D, Hrycyna CA, Chmielewski J. Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers. Mol Pharmacol 2009; 75: 92-100.
37. Tanaka S, Masuda M, Nakajima K, Ido N, Ohtsuka T, Nishida M, et al. P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration. Int Immunopharmacol 2009; 9: 284-90.
38. Tomita M, Kishimoto H, Takizawa Y, Hayashi M. Effects of intestinal ischemia/reperfusion on P-glycoprotein mediated biliary and renal excretion of rhodamine123 in rat. Drug Metab Pharmacokinet 2009; 24: 428-37.
39. Kato R, Moriguchi J, Irie T, Nakagawa M, Kusukawa Y, Matsumura H, et al. Effects of lipopolysaccharide on P-glycoprotein expression and activity in the liver and kidneys. Eur J Pharmacol 2010; 636: 155-8.
40. Cermanova J, Fuksa L, Brcakova E, Hroch M, Kucera O, Kolouchova G, et al. Up-regulation of renal Mdr1 and Mrp2 transporters during amiodarone pretreatment in rats. Pharmacol Res 2010; 61: 129-35.
41. Borbás T, Benko B, Dalmadi B, Szab I, Tihanyi K. Insulin in flavincontaining monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes. Eur J Pharm Sci 2006; 28: 51-8.
42. Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol 2006; 291: 2660-8.
43. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005; 57: 173-85. (Pubitemid 41043883)
44. Hawkins BT, Ocheltree SM, Norwood KM, Egleton RD. Decreased blood-brain barrier permeability to fluorescein in streptozotocintreated rats. Neurosci Lett 2007; 411: 1-5. (Pubitemid 44751936)
45. Goralski KB, Hartmann G, Piquette-Miller M, Renton KW. Down regulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 2003; 139: 35-48. (Pubitemid 36645306)
46. Kathryn T. Dyslipidaemia, inflammation and endothelial dysfunction in diabetes mellitus. Int Congr Ser 2004; 1262: 511-4.
47. Tambur AR, Markham PN, Gebel HM. IL-4 Inhibits P-Glycoprotein in normal and malignant NK cells. Hum Immunol 1998; 59: 483-7. (Pubitemid 28354966)
48. Liu YC, Liu HY, Yang HW, Wen T, Shang Y, Liu XD, et al. Impaired expression and function of breast cancer resistance protein (Bcrp) in brain cortex of streptozocin-induced diabetic rats. Biochem Pharmacol 2007; 74: 1766-72. (Pubitemid 350088680)
49. Zhao YL, Du J, Kanazawa H, Sugawara A, Takagi K, Kitaichi K, et al. Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice. Eur J Pharmacol 2002; 445: 115-23. (Pubitemid 34628440)
50. Heemskerk S, van Koppen A, van den Broek L, Poelen GJ, Wouterse AC, Dijkman HB, et al. Nitric oxide differentially regulates renal ATPbinding cassette transporters during endotoxemia. Pflugers Arch 2007; 454: 321-34. (Pubitemid 46525464)
51. Anger GJ, Magomedova L, Piquette-Miller M. Impact of acute streptozotocin-induced diabetes on ABC transporter expression in rats. Chem Biodivers 2009; 6: 1943-59.
52. Reichel V, Burghard S, John I, Huber O. P-glycoprotein and breast cancer resistance protein expression and function at the bloodbrain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats. Brain Res 2011; 1370: 238-45.
53. Liu Y, Liu H, Yang J, Liu X, Lu S, Wen T, et al. Increased amyloid betapeptide (1-40) level in brain of streptozotocin-induced diabetic rats. Neuroscience 2008; 153: 796-802.
54. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 1992; 267: 24248-52.
55. Miyazawa T, Kubo E, Takamura Y, Akagi Y. Up-regulation of P-glycoprotein expression by osmotic stress in rat sugar cataract. Exp Eye Res 2007; 84: 246-53. (Pubitemid 44970456)
56. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-78. (Pubitemid 33716379)
57. Goodyer IM, Herbert J, Tamplin A, Altham PM. First-episode major depression in adolescents. Affective, cognitive and endocrine characteristics of risk status and predictors of onset. Br J Psychiatry 2000; 176: 142-9. (Pubitemid 32734839)